Self-confidence and self-reliance might seem like two sides of the same coin, but they each tell a unique story of strength. Self-confidence is that inner spark, pushing you to believe in your own potential. Self-reliance? It’s about standing tall on your own while still lifting others up. For a nation, self-reliance is about breaking free from relying too much on imports and building a future that’s strong and sustainable. When one country gets this right, it doesn’t just shine on its own, it lights the way for the world.
The United Arab Emirates is on a bold journey to shape a self-reliant and resilient future. From food and energy to economic development, the country is focused on strengthening its foundations across every sector. As part of this vision, the UAE is diversifying its economy by investing in advanced technologies and supporting homegrown talent. At the heart of this effort is the Ministry of Industry and Advanced Technology’s “Make it in the Emirates” campaign—an open invitation for businesses to imagine, create, and grow within the country. It’s a call to build not just products, but a future defined by innovation, sustainability, and national pride.
Make it in the Emirates Initiative
“Make it in the Emirates” is a national initiative launched by the UAE Ministry of Industry and Advanced Technology (MoIAT) to strengthen local manufacturing, attract investments, and drive economic diversification. The initiative encourages both local and international investors, industrialists, and innovators to manufacture in the UAE by offering incentives, world-class infrastructure, and access to strategic markets.
The momentum generated in the healthcare sector is part of a broader shift toward integrated self-reliance, where innovation, investment, and infrastructure development go hand in hand.
Aligned with the UAE’s vision for long-term sustainable development, the initiative supports industrial self-sufficiency, job creation, and the growth of advanced industries, helping the country’s global competitiveness.
While the initiative covers multiple sectors, healthcare is also a key area of focus. Let’s take a closer look at how “Make it in the Emirates” is shaping the future of healthcare in the UAE.
The Healthcare Connection
The “Make it in the Emirates” initiative in healthcare is all about the UAE taking charge of its future by producing vital medical and healthcare products right at home. It’s a key part of the country’s bold plan to grow its industries and become more self-reliant. From pharmaceuticals and medical devices to personal protective equipment and leading-edge biotechnology, the UAE is building its own solutions to meet its healthcare needs. By teaming up with global companies, offering attractive incentives, and tapping into top-notch infrastructure, the initiative invites investment to strengthen the health sector. This isn’t just about securing supply chains, it’s about building a resilient, sustainable future that supports the UAE’s Vision 2031 for a thriving, knowledge-driven economy
Strengthening Healthcare Locally
The “Make it in the Emirates” campaign has altered healthcare in the United Arab Emirates by emphasizing domestic production in order to establish a strong, independent healthcare system. It’s not just about growing the economy; it’s also about making sure the UAE is prepared for everything, from ordinary medical requirements to international emergencies. The COVID-19 pandemic brought to light the risks associated with importing necessities such as masks, testing, and medications. By manufacturing these domestically, the UAE is protecting itself against supply chain interruptions and guaranteeing consistent access to treatment for everyone, whether for routine checkups, chronic illnesses, or emergencies.
Innovation is also being encouraged by this demand for local manufacture. In order to transform the UAE into a global healthcare player rather than just a consumer, UAE-based businesses are entering into biotech, clinical trials, and research. Additionally, it’s opening up interesting new employment paths in research, technology, and regulation for Emiratis. Incorporating healthcare within its industrial strategy has assisted the UAE create an enduring and progressive system. It’s about better care for everyone, affordability, and sovereignty. In addition to preparing for the future, the UAE is creating a stronger, healthier future with each locally produced medication or equipment.
UAE Advances Healthcare Production
As the UAE accelerates its national industrial strategy through the “Make it in the Emirates” initiative, the healthcare sector is emerging as a core pillar, combining industrial innovation with public health resilience. The initiative is not only catalyzing local pharmaceutical production and medical technology development but also drawing global players and regional champions into strategic alignments that shape the future of healthcare manufacturing.
One of the most significant recent milestones comes from Globalpharma, the UAE’s leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments. At the 2025 edition of the “Make it in the Emirates” forum, Globalpharma signed four strategic memorandums of understanding (MoUs) with leading international and regional players. These partnerships span the production of biosimilars, advanced therapeutics, and specialized dosage forms, showing a clear ambition to scale up capabilities in high-value pharmaceutical segments.
These MoUs are not mere commercial gestures. They demonstrate the UAE’s commitment to health independence, a move toward reducing dependency on imported essential drugs while encouraging technology transfer, clinical collaboration, and talent development within the Emirates. With production expected to serve both domestic and GCC markets, Globalpharma is a prime example of how national manufacturers are advancing into regional pharmaceutical leaders under the banner of this initiative.
In parallel, Mubadala Investment Company has unveiled a bold step into the pharmaceutical space with the launch of a new pharma platform operating across three continents. Announced in May 2025, this new entity consolidates pharmaceutical assets from the UAE, Europe, and the US, and aims to produce a wide range of treatments including oncology, rare disease therapies, and biologics. The platform is designed not just for global competitiveness but also for strategic alignment with the UAE’s local manufacturing goals.
Mubadala’s new venture illustrates how sovereign investment is now being strategically deployed to accelerate health sector self-reliance. With a focus on R&D-intensive and globally regulated products, the initiative marks a new chapter in the UAE’s ambition to participate in the innovation economy and not just the generic drug market.
Beyond pharmaceuticals, medical device manufacturing and diagnostics are also gaining momentum. Local partnerships with tech providers are enabling the production of critical tools such as test kits, 3D-printed prosthetics, and surgical equipment. Hospitals and healthcare groups have begun sourcing select categories of consumables and devices locally, supporting the development of a more resilient health supply chain.
One of the early successes of the “Make it in the Emirates” campaign was the establishment of Hayat Biotech, which partnered with Sinopharm to locally produce COVID-19 vaccines. This not only enabled the UAE to manage pandemic logistics more efficiently but also laid the foundation for future biologics manufacturing, including plans for locally developed vaccines and cell-based therapies.
The pharmaceutical transformation is further supported by Julphar (Gulf Pharmaceutical Industries) in Ras Al Khaimah, which has restructured its operations and expanded its portfolio to include high-demand therapeutic areas such as diabetes and cardiovascular diseases. With export ambitions and a focus on regulatory excellence, Julphar is part of the national push toward global competitiveness.
‘Make it in the Emirates’ is building more than factories, it is building capability, credibility, and confidence.
Collectively, these developments reflect how the healthcare segment is driving economic diversification, job creation, and technological advancement under “Make it in the Emirates.” Supported by the Ministry of Industry and Advanced Technology and local health authorities, the initiative is designed not only to enhance the country’s industrial output but also to ensure that healthcare innovation, access, and security are firmly rooted within the UAE’s borders.
In an increasingly uncertain global environment, the UAE’s healthcare manufacturing ambitions are as much about resilience as they are about leadership, positioning the country to serve as a regional hub for health sciences, biomanufacturing, and therapeutic innovation for years to come.
Global Health Leadership
What sets the UAE’s strategy apart is its ability to align national vision with industry execution, creating an environment where innovation, investment, and regulatory support work cohesively. Under the guidance of the Ministry of Industry and Advanced Technology (MoIAT), and in collaboration with health sector partners such as the Department of Health – Abu Dhabi and Dubai Health Authority, the country has introduced a comprehensive framework of incentives, industrial financing options, land access, and fast-track licensing to attract investors and manufacturers in the life sciences domain.
These strategic moves are already showing results. Abu Dhabi’s Life Sciences Hub has attracted global pharmaceutical giants like Roche, Pfizer, and GlaxoSmithKline, while Dubai Science Park is home to over 400 companies in pharmaceuticals, diagnostics, and biotechnology. Many of these companies are now not only operating regional offices but actively contributing to local production, R&D, and training programs, reinforcing the UAE’s ambition to become a regional leader in advanced healthcare solutions.
Adding to this growing momentum is the In-Country Value (ICV) program, which puts a strong focus on local sourcing and the development of Emirati talent. High ICV scores across key healthcare organizations highlight a deep commitment to strengthening the UAE’s healthcare ecosystem from within. These efforts are visible in actions like sourcing medical supplies locally, partnering with UAE-based research institutions, and building long-term training pathways for Emiratis in areas such as biotechnology and regulatory science.
The goal is not just self-reliance, it is global relevance. By integrating R&D capabilities, global partnerships, and a strong regulatory framework, the UAE is preparing to transition from an importer of healthcare innovation to a net exporter of high-value medical products and technologies. As the ecosystem matures, the country is positioning itself as a center of excellence for manufacturing, innovation, and knowledge-sharing across the Middle East and beyond, anchoring its healthcare strategy in sustainability, resilience, and forward-thinking leadership.
Preparing Healthcare Tomorrow
The “Make it in the Emirates” initiative is not just a manufacturing drive, it is a strategic foundation for building national health resilience. With robust participation from local manufacturers, sovereign entities like Mubadala, and global pharma leaders, the initiative is translating policy into real-world transformation. It is equipping the country to manage future health challenges with agility, while ensuring that critical supplies, from medications to diagnostics, are produced within national borders.
The momentum generated in the healthcare sector is part of a broader shift toward integrated self-reliance, where innovation, investment, and infrastructure development go hand in hand. Programs like the In-Country Value (ICV) scorecard are ensuring that manufacturing is tied to knowledge transfer, job creation, and technology localization, outcomes that directly serve long-term health system sustainability.
By nurturing advanced research hubs and enabling clinical trials in partnership with leading academic institutions, the UAE is steadily advancing into the biotech and precision medicine space, areas that will define the future of global healthcare. This is not just about reducing imports, it is about elevating the UAE’s role in shaping regional and international health outcomes.
In essence, “Make it in the Emirates” is building more than factories, it is building capability, credibility, and confidence. It offers a replicable model for other nations seeking to align industrial policy with public health goals. For the UAE, this journey marks a strategic leap, from healthcare preparedness to healthcare leadership.
